Cointime

Biotech Turnaround Fund (BTF)

investment firm

About

Biotech Turnaround Fund (BTF) B.V. is a cross-over, turnaround venture capital operating company, focusing on building a portfolio of six

Highlights

Investments
7
Lead Investments
1
Exits
1

Details

Founded date
Jan 1, 2000
Operating Status
Active
Investor Type
Venture Capital

Biotech Turnaround Fund (BTF) B.V. is a cross-over, turnaround venture capital operating company, focusing on building a portfolio of six late-stage biotechnology companies. Companies with several drug development candidates in phase II clinical trials.

Investments

Number of Investments
Number of Lead Investments
7
1
Biotech Turnaround Fund (BTF) has made 7 investments. Their most recent investment was on Jan 1, 2008, when Genizon BioSciences raised $30.81M.
Date Company Name
Round Money Raised Industry Lead Investor
Jan 1, 2008 Genizon BioSciences
Series E $30.81M Biotechnology Yes
Apr 19, 2007 CymaBay Therapeutics
Series D $32M Biopharma —
Feb 5, 2007 Genizon BioSciences
Series D $10M Biotechnology —
Aug 29, 2003 CymaBay Therapeutics
Series A $27M Biopharma —
Feb 25, 2003 Genizon BioSciences
Series Unknown $7.70M Biotechnology —
Show More

Exits

Biotech Turnaround Fund (BTF) has had 1 exits. Biotech Turnaround Fund (BTF) most notable exits include CymaBay Therapeutics

Date Company Name Exit Type Industry
Jul 18, 2014 CymaBay Therapeutics IPO Biopharma Detail
Cointime
Содержание
компания